Nervous system
medicines for cancer
patients and survivors
We are developing neuroplastogens for cancer supportive care, starting with the memory and attention problems that can follow cancer treatment.
Addressing the effects
of cancer and its treatment
Cancer and its treatment can affect memory, attention, energy and everyday activities.
Our team combines medicinal chemistry, neuroscience and clinical development to study potential treatments for these problems. We aim to develop medicines that can be used in routine oncology care.
The science behind our approachCancer-related
cognitive impairment
Research into treatments
for “chemo brain”
TL-01 is our lead neuroplastogen program. We are studying its potential as an oral treatment for the cognitive difficulties that can follow cancer treatment.
Its potential benefits, effects in people and clinical treatment requirements remain to be established.
Explore the lead programExperience in chemistry,
neuroscience and clinical development
Our founders have experience in medicinal chemistry, CNS drug development and company building. Our scientific advisors contribute expertise in psychiatry, CNS drug development and translational research.
Get updates on future clinical trial opportunities
Receive an email when Telesti announces future clinical trial opportunities. Signing up does not enroll you in a trial.